G. Wigbout

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2

E. Mariman, L. J. Veer, H. Brunner, 1999, British Journal of Cancer.

The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure.

N. van Zandwijk, F. V. van Schooten, J. Kleinjans, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

32P-postlabelling of aromatic DNA adducts in white blood cells and alveolar macrophages of smokers: saturation at high exposures.

L. V. van't Veer, P. Baas, R. Godschalk, 1997, Mutation research.

Toxicity grading systems. A comparison between the WHO scoring system and the Common Toxicity Criteria when used for nausea and vomiting.

A. C. Dubbelman, O. Dalesio, N. Aaronson, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Late-Onset Common Cancers in a Kindred with an Arg213Gln TP53 Germline Mutation

D. Jong, L. J. Veer, A. Floore, 2005, Familial Cancer.

Toxicity grading systems

N. Aaronson, B. Taal, I. Mandjes, 1992 .

Smokers and urinary genotoxins: Implications for selection of cohorts and modulation of endpoints in chemoprevention trials

S. De Flora, N. van Zandwijk, G. Qian, 1996, Journal of cellular biochemistry. Supplement.